0
Press Releases
2012
February 3, 2012 - DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs
2011
November 29, 2011 - Compugen and DiscoveRx® Form Collaboration to Commercialize Novel Peptide Ligands for GPCR Drug Targets
November 16, 2011 - DiscoveRx® Corporation's KINOMEscan™ Technology Reveals Kinome-wide Fingerprints Against Diverse Set of Mature Kinase Inhibitors and FDA Approved Therapeutics
September 6, 2011 - An Unprecedented Industry-Academia Alliance to Accelerate GPCR Deorphanization Efforts
June 2, 2011 - DiscoveRx Corporation Announces the Expansion of KINOMEscan's Largest Commercially Available Kinase Panel
2010
June 1, 2010 - DiscoveRx Corporation Expands its GPCR Technology Portfolio to Include Advanced Technologies that Facilitate Lead Optimization and SAR
January 13, 2010 - DiscoveRx adds new products and services to augment its comprehensive portfolio of the largest non-force coupled GPCR assays and reagents
January 11, 2010 - DiscoveRx Corp. & Jubilant Biosys Limited announce Co-Marketing Agreement for Screening Services
2009
October 20, 2009 - Evotec Signs Agreement with DiscoveRx Corporation to Support High Throughput Screening Services
October 8, 2009 - DiscoveRx and BioFocus announce a co-marketing agreement for GPCR screening
October 1, 2009 - DiscoveRx signs a worldwide agreement with GlaxoSmithKline (GSK) that allows GSK, access to PathHunter™ ß-Arrestin cell lines and reagents for GPCR screening
September 23, 2009 - Industry and academia team up in three-way collaboration to identify natural substances that can bind to orphan G protein-coupled receptors. Findings could lead to new targets for drug discovery
January 13, 2009 - DiscoveRx Adds New Products and Services to Augment its Comprehensive Portfolio of the Largest Non-force Coupled GPCR Assays and Reagents
2008
November 17, 2008 - Frost & Sullivan Recognizes Excellence in Healthcare Innovation Distinguished Companies to Usher in New Era in Healthcare
September 10, 2008 - Frost & Sullivan Recognizes DiscoveRx with Product Line Strategy Award
March 03, 2008 - DiscoveRx Corporation Develops a Highly Sensitive and Quantitative Fluorescence Assay for PI3 Kinase
February 06, 2008 - DiscoveRx Corporation Signs Agreement with Cosmo Bio Co., Ltd. for Drug Discovery Screening Services Representation in Japan
Copyright ©2009, DiscoveRx Corporation. TERMS AND CONDITIONS